Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Juandy Jo
Vaccines | Free Full-Text | The Improvement of Adaptive Immune Responses towards COVID-19 Following Diphtheria-Tetanus-Pertussis and SARS-CoV-2 Vaccinations in Indonesian Children: Exploring the Roles of Heterologous Immunity
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
The Improvement of Adaptive Immune Responses towards COVID-19 Following Diphtheria-Tetanus-Pertussis and SARS-CoV-2 Vaccinations in Indonesian Children: Exploring Roles of Heterologous Immunity
Preprint Article Version 1 This version is not peer-reviewed Version 1 : Received: 12 July 2024 / Approved: 15 July 2024 / Online: 17 July 2024 (04:12:51 CEST) Santi, T.; Jo, J.; Harahap, A. R.; Werdhani, R. A.; Hadinegoro, S. R. S.; SahBandar, I. N.; Prayitno, A.; Munasir, Z.; Vandenplas, Y.; Hegar, B. The Improvement of Adaptive Immune Responses towards COVID-19 Following Diphtheria-Tetanus-Pertussis and SARS-CoV-2 Vaccinations in Indonesian Children: Exploring Roles of Heterologous Immunity.
Lactose Intolerance versus Cow’s Milk Allergy in Infants: A Clinical Dilemma
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Serum protein biomarkers for HCC risk prediction in HIV/HBV co-infected people: a clinical proteomic study using mass spectrometry
Introduction Hepatocellular carcinoma (HCC) is the sixth most common cancer and the second leading cause of cancer-related deaths worldwide, killing over 700,000 people each year (1, 2). In contrast to most solid tumors, the prevalence of HCC and HCC-related mortality has risen in recent decades. Chronic hepatitis B virus (HBV) and chronic hepatitis C virus (HCV) infection are the most important causes of HCC.
Single-cell landscape of immune cells during the progression from HBV infection to HBV cirrhosis and HBV-associated hepatocellular carcinoma
Introduction Hepatitis B virus (HBV) is a communicable chronic disease that poses a significant threat to public health. It is estimated that approximately 296 million people worldwide are infected with HBV, resulting in 1 million deaths annually (1). HBV is a hepatotropic virus that causes hepatocyte injury, immune cell infiltration, and liver fibrosis (2). As a result, patients may develop liver cirrhosis and hepatocellular carcinoma (HCC) (3).
Presence of MDSC associates with impaired antigen-specific T cell reactivity following COVID-19 vaccination in cirrhotic patients
1 Introduction Cirrhosis is associated with systemic inflammation and immunodeficiency, a state often referred to as cirrhosis-associated immune dysfunction (1, 2).
Hepatitis D infection induces IFN-β-mediated NK cell activation and TRAIL-dependent cytotoxicity
1 Introduction The HDV affects at least 12 million people worldwide (1). The HDV is a small, single-stranded negative-sense RNA virus, capable of infecting hepatocytes. For the formation and secretion of progeny virus the HDV requires the envelope protein of the HBV. Recent studies demonstrated cell division-mediated intrahepatic spread of HDV-mono-infected cells in humanized mouse models and in vitro (2–4).
Type III interferon exerts thymic stromal lymphopoietin in mediating adaptive antiviral immune response
1 Introduction The interferon (IFN) response is a critical host defense mechanism against viral or microbial infections. According to sequence homology, IFNs can be subdivided into type I (IFN-I), type II (IFN-II), and type III IFNs (IFN-III).
Serum cytokine and chemokine profiles and disease prognosis in hepatitis B virus-related acute-on-chronic liver failure
Bingbing Zhu†, Fangyuan Gao†, Yuxin Li, Ke Shi, Yixin Hou, Jialiang Chen, Qun Zhang and Xianbo Wang* Center of Integrative Medicine, Beijing Ditan Hospital, Capital Medical University, Beijing, China Background: Hepatitis B virus-related acute-on-chronic liver failure (HBV-ACLF) has significant morbidity and mortality and is associated with the induction of cytokines/chemokines, which might contribute to the pathogenesis of liver injury.
Host immunity and HBV S gene mutation in HBsAg-negative HBV-infected patients
Hepatitis B virus (HBV) infection is a major global health problem. According to the latest data released by the WHO in 2020, there are approximately 257 million cases of chronic HBV infection worldwide. Moreover, approximately 887,000 people die each year due to uncompensated liver cirrhosis, liver failure, primary liver cancer and other end-stage liver diseases caused by HBV infection, indicating that the HBV infection rate has not decreased (1).
Identification of Peptides with Tolerogenic Potential in a Hydrolyzed Whey‐Based Infant Formula
Background Failure to induce oral tolerance may result in food allergy. Hydrolyzed cow's milk‐based infant formulas are recommended in subjects with a high risk of developing allergic disease. Presentation of T‐cell epitopes is a prerequisite to generate regulatory T cells that could contribute to oral tolerance. Objective To investigate whether a specific hydrolyzed whey‐based infant formula contains peptides that function as T‐cell epitopes to support the development of oral tolerance to whey.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Juandy
Contact Juandy, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack